(Q38323856)

2 September 2017

title

Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells (English)

1 reference

2 September 2017

11

1 reference

2 September 2017

Lifeng Feng

1

1 reference

2 September 2017

Min Pan

2

1 reference

2 September 2017

Jie Sun

3

1 reference

2 September 2017

Haiqi Lu

4

1 reference

2 September 2017

Qi Shen

5

1 reference

2 September 2017

Shengjie Zhang

6

1 reference

2 September 2017

Tingting Jiang

7

1 reference

2 September 2017

Liangyi Liu

8

1 reference

2 September 2017

Wei Jin

9

1 reference

2 September 2017

Yan Chen

10

1 reference

2 September 2017

Hongchuan Jin

12

1 reference

2 September 2017

publication date

5 July 2012

1 reference

Journal of Molecular Medicine

2 September 2017

published in

1 reference

2 September 2017

volume

91

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

49-58

1 reference

2 September 2017

cites work

Focus on gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Cancer epigenetics: modifications, screening, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Germline histone dynamics and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

HDACs and HDAC inhibitors in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Isoform-selective histone deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Rational combinations using HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

PUMA induces the rapid apoptosis of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Puma is required for p53-induced depletion of adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Variation in gene expression patterns in human gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

PUMA couples the nuclear and cytoplasmic proapoptotic function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Acetylation is indispensable for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0932-X

Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.

21 January 2018

1 reference

12 December 2020

Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines

1 reference

12 December 2020

Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.

1 reference

12 December 2020

Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells

1 reference

12 December 2020

10.1007/S00109-012-0932-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1033794410

0 references

1 reference